-
免疫球蛋白G4相关疾病(immunoglobulin G4-related disease,IgG4-RD)是一种罕见的、进行性加重的全身炎症性疾病,常伴血清IgG4水平异常升高。IgG4阳性浆细胞浸润和席纹状纤维化是其主要的组织病理学特点,其潜在的受累部位包括胰腺、垂体、硬脑膜、眼眶、副鼻窦、甲状腺、乳腺、肺、肝脏、胆道、肾脏、前列腺、腹膜后和皮肤[1]。当IgG4-RD累及心血管系统时可导致IgG4相关心血管疾病(IgG4-related cardiovascular disease,IgG4-RCVD)。IgG4-RCVD的病变部位以冠状动脉、心脏瓣膜、心肌、心包、主动脉、肺部血管和全身周围血管等多见[2]。病灶组织活检是诊断IgG4-RCVD的重要手段,但其为有创性检查且操作难度较大。18F-FDG PET/CT集功能显像和解剖显像于一体,可以同时提供病灶形态、密度及功能代谢的双模态信息。IgG4-RCVD受累部位IgG4阳性浆细胞聚集且高表达葡萄糖转运蛋白,18F-FDG PET/CT基于IgG4-RCVD患者病变部位的代谢程度在全身范围内评估血管炎症的范围和程度。18F-FDG PET/CT作为一种更直观、更全面的检查手段,在诊断和定量评估血管炎症、指导活检部位选择以及疗效监测等方面起关键作用。本文对18F-FDG PET/CT在IgG4-RCVD中的应用进展进行综述。
18F-FDG PET/CT在IgG4相关心血管疾病中的应用进展
Research progress of 18F-FDG PET/CT in IgG4 related cardiovascular diseases
-
摘要: 免疫球蛋白G4相关疾病(IgG4-RD)是一种全身炎症性疾病,通常累及多个器官。IgG4相关心血管疾病(IgG4-RCVD)包括IgG4相关主动脉病变、IgG4相关冠状动脉病变、IgG4相关肺动脉病变和IgG4相关心包炎。IgG4-RCVD受累部位IgG4阳性浆细胞聚集并高表达葡萄糖转运蛋白。18F-氟脱氧葡萄糖(FDG)PET/CT可以基于IgG4-RCVD患者病变部位的代谢程度在全身范围内评估血管炎症的范围和程度,在诊断和定量评估IgG4-RCVD血管炎症、指导活检部位选择以及疗效监测等方面起到关键作用。笔者对18F-FDG PET/CT在IgG4-RCVD应用中的进展进行综述,以期为临床医师通过18F-FDG PET/CT诊断IgG4-RCVD提供参考。
-
关键词:
- 氟脱氧葡萄糖F18 /
- 正电子发射断层显像术 /
- 体层摄影术,X线计算机 /
- 免疫球蛋白G4相关疾病 /
- 免疫球蛋白G4相关心血管疾病
Abstract: Immunoglobulin G4-related disease (IgG4-RD) is a type of systemic inflammatory diseases that often affect multiple organs. IgG4-related cardiovascular disease (IgG4-RCVD) includes IgG4-related aortic disease, IgG4-related coronary artery disease, IgG4-related pulmonary artery disease, and IgG4-related pericarditis. IgG4-positive plasma cells accumulate and exhibit high expression of glucose transport proteins at the site of IgG4-RCVD involvement. 18F-fluorodeoxyglucose (FDG) PET/CT can assess the extent and degree of vascular inflammation on a systemic scale by evaluating the metabolic activity of lesions in IgG4-RCVD patients. It plays a pivotal role in diagnosing and quantitatively assessing IgG4-RCVD vascular inflammation, aiding in the selection of biopsy sites, and monitoring treatment efficacy. The authors conducted a comprehensive review of the advancements in the utilization of 18F-FDG PET/CT for IgG4-RCVD, aiming to furnish clinicians with a valuable reference for diagnosing IgG4-RCVD through the application of 18F-FDG PET/CT. -
[1] Sánchez-Oro R, Alonso-Muñoz EM, Martí Romero L. Review of IgG4-related disease[J]. Gastroenterol Hepatol, 2019, 42(10): 638−647. DOI: 10.1016/j.gastrohep.2019.08.009. [2] Mavrogeni S, Markousis-Mavrogenis G, Kolovou G. IgG4-related cardiovascular disease. The emerging role of cardiovascular imaging[J]. Eur J Radiol, 2017, 86: 169−175. DOI: 10.1016/j.ejrad.2016.11.012. [3] Peng LY, Zhang PP, Li JQ, et al. IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease[J]. Arthritis Res Ther, 2020, 22(1): 103. DOI: 10.1186/s13075-020-02197-w. [4] Xiao X, Lian M, Zhang WC, et al. The immunologic paradoxes of IgG4-related disease[J]. Clin Rev Allergy Immunol, 2018, 54(2): 344−351. DOI: 10.1007/s12016-018-8679-y. [5] Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease[J]. Curr Opin Rheumatol, 2011, 23(1): 88−94. DOI: 10.1097/BOR.0b013e3283 412f7c. [6] Oyama-Manabe N, Yabusaki S, Manabe O, et al. IgG4-related cardiovascular disease from the aorta to the coronary arteries: multidetector CT and PET/CT[J]. Radiographics, 2018, 38(7): 1934−1948. DOI: 10.1148/rg.2018180049. [7] Pérez-García CN, Olmos C, Vivas D, et al. IgG4-aortitis among thoracic aortic aneurysms[J]. Heart, 2019, 105(20): 1583−1589. DOI: 10.1136/heartjnl-2018-314499. [8] Zhang JJ, Chen H, Ma YR, et al. Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study[J]. Eur J Nucl Med Mol Imaging, 2014, 41(8): 1624−1634. DOI: 10.1007/s00259-014-2729-3. [9] Yabusaki S, Oyama-Manabe N, Manabe O, et al. Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography[J/OL]. EJNMMI Res, 2017, 7(1): 20[2023-03-06]. https://ejnmmires.springeropen.com/articles/10.1186/s13550-017-0268-1. DOI: 10.1186/s13550-017-0268-1. [10] Mitamura K, Arai-Okuda H, Yamamoto Y, et al. Disease activity and response to therapy monitored by [18F]FDG PET/CT using volume-based indices in IgG4-related disease[J/OL]. EJNMMI Res, 2020, 10(1): 153[2023-03-06]. https://ejnmmires.springeropen.com/articles/10.1186/s13550-020-00743-w. DOI: 10.1186/s13550-020-00743-w. [11] Fathala A. Multimodalities imaging of immunoglobulin 4-related cardiovascular disorders[J]. Curr Cardiol Rev, 2019, 15(3): 224−229. DOI: 10.2174/1573403X15666190117101607. [12] Löffler C, Hoffend J, Rebel M, et al. A rare cause for lower back pain: a case of an IgG4-related periaortitis[J]. Clin Rheumatol, 2016, 35(1): 265−270. DOI: 10.1007/s10067-014-2535-0. [13] Nikiphorou E, Galloway J, Fragoulis GE. Overview of IgG4-related aortitis and periaortitis. A decade since their first description[J]. Autoimmun Rev, 2020, 19(12): 102694. DOI: 10.1016/j.autrev.2020.102694. [14] Perugino CA, Wallace ZS, Meyersohn N, et al. Large vessel involvement by IgG4-related disease[J]. Medicine (Baltimore), 2016, 95(28): e3344. DOI: 10.1097/MD.0000000000003344. [15] Ramdin N, Orde M, O'neill SB, et al. Hidden IgG4-related coronary disease: an autopsy study[J]. Am J Clin Pathol, 2021, 156(3): 471−477. DOI: 10.1093/ajcp/aqaa258. [16] Huang HL, Fong W, Peh WM, et al. The utility of FDG PET/CT in IgG4-related disease with a focus on coronary artery involvement[J]. Nucl Med Mol Imaging, 2018, 52(1): 53−61. DOI: 10.1007/s13139-017-0494-5. [17] Tsuji S, Iwamoto N, Horai Y, et al. Comparison of the quantitative measurement of 18F-FDG PET/CT and histopathological findings in IgG4-related disease[J]. Clin Exp Rheumatol, 2021, 39(6): 1338−1344. DOI: 10.55563/clinexprheumatol/bsrhey. [18] Fragoulis GE, Evangelatos G, Tektonidou MG. Vasculitis beyond aortitis in IgG4-related disease (IgG4-RD): case report and review of the literature[J]. Clin Rheumatol, 2021, 40(3): 1167−1173. DOI: 10.1007/s10067-020-05302-1. [19] Xu X, Bai W, Ma H, et al. Remission of "mistletoe sign" after treatment[J]. J Cardiovasc Comput Tomogr, 2020, 14(6): e118−e119. DOI: 10.1016/j.jcct.2019.08.002. [20] Russo V, Lovato L, Ligabue G. Cardiac MRI: technical basis[J]. Radiol Med, 2020, 125(11): 1040−1055. DOI: 10.1007/s11547-020-01282-z. [21] Delgado-García G, Sánchez-Salazar S, Rendón-Ramírez E, et al. Myocardial ischemia as presenting manifestation of IgG4-related disease: a case-based review[J]. Clin Rheumatol, 2016, 35(11): 2857−2864. DOI: 10.1007/s10067-016-3292-z. [22] Dong AS, Wang Y, Zuo CJ. FDG PET/CT in IgG4-related peripulmonary arteritis[J]. Clin Nucl Med, 2016, 41(10): e439−e440. DOI: 10.1097/RLU.0000000000001208. [23] Zhou Y, Shao LY, Ruan WJ, et al. Pulmonary vascular involvement of IgG4-related disease: case series with a PRISMA-compliant systemic review[J]. Medicine (Baltimore), 2019, 98(6): e14437. DOI: 10.1097/MD.0000000000014437. [24] Deng H, Zhao S, Yue YL, et al. IgG4-related disease of pulmonary artery causing pulmonary hypertension[J]. Medicine (Baltimore), 2018, 97(20): e10698. DOI: 10.1097/MD.0000000000010698. [25] Friedberg MK. Imaging right-left ventricular interactions[J]. JACC Cardiovasc Imaging, 2018, 11(5): 755−771. DOI: 10.1016/j.jcmg.2018.01.028. [26] 薛志伟, 赵倩, 宋丽俊, 等. 经胸超声心动图联合CT对缩窄性心包炎的诊断价值[J]. 中国CT和MRI杂志, 2021, 19(1): 95−97. DOI: 10.3969/j.issn.1672-5131.2021.01.033.
Xue ZW, Zhao Q, Song LJ, et al. Diagnostic value of transthoracic echocardiography combined with CT in constrictive pericarditis[J]. Chin J CT MRI, 2021, 19(1): 95−97. DOI: 10.3969/j.issn.1672-5131.2021.01.033.[27] Matsuda J, Takano H, Shimizu W. IgG4-related periarteritis in the coronary artery and subclinical pericarditis assessed the presence and monitoring of therapy response by PET and CT scan[J/OL]. BMJ Case Rep, 2018, 2018: bcr2018225172[2023-03-06]. https://casereports.bmj.com/content/2018/bcr-2018-225172.long. DOI: 10.1136/bcr-2018-225172. [28] Matsumiya R, Hosono O, Yoshikawa N, et al. Elevated serum IgG4 complicated by pericardial involvement with a patchy 18F-FDG uptake in PET/CT: a typical presentation of IgG4-related disease[J]. Intern Med, 2015, 54(18): 2337−2341. DOI: 10.2169/internalmedicine.54.4340. [29] Manabe O, Yoshinaga K, Ohira H, et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial 18F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis[J]. J Nucl Cardiol, 2016, 23(2): 244−252. DOI: 10.1007/s12350-015-0226-0.
计量
- 文章访问数: 3219
- HTML全文浏览量: 3193
- PDF下载量: 2